Emmanuel Lemelson

SEC Sues Priest/Hedge Fund Manager for Stock Manipulation

September 18, 2018 James Heinsman Hedge Fund News

The SEC filed a suit against Emmanuel Lemelson, a Massachusetts priest who also works as a hedge fund manager, for publishing false “research reports” in order to push the share price of Ligand Pharmaceuticals, Inc, down. The suit accuses Lemelson and his firm Lemelson Capital Management, of publishing misleading/false reports on popular investing websites like […]

More

Emmanuel Lemelson, Lemelson Capital Management, Ligand Pharmaceuticals, SEC, stock manipulation,

Powered by WordPress. Designed by elogi.